ReviewClinical drug investigation2023

Avacopan, a Novel Competitive C5a Receptor Antagonist, for Severe Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.

Ivan D Nguyen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.